AEMD Stock Summary and Trading Ideas (Aethlon Medical | NASDAQ:AEMD)

Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.

Aethlon Medical trades on the NASDAQ stock market under the symbol AEMD.

As of December 31, 2025, AEMD stock price declined to $2.54 with 5,068 million shares trading.

AEMD has a beta of 1.41, meaning it tends to be more sensitive to market movements. AEMD has a correlation of 0.03 to the broad based SPY ETF.

AEMD has a market cap of $2.47 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, AEMD traded as high as $696.00 and as low as $2.44.

The top ETF exchange traded funds that AEMD belongs to (by Net Assets): VXF.

AEMD has underperformed the market in the last year with a price return of -95.2% while the SPY ETF gained +17.7%. AEMD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -66.1% and -13.6%, respectively, while the SPY returned +3.2% and +1.2%, respectively.

AEMD support price is $2.47 and resistance is $2.91 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AEMD shares will trade within this expected range on the day.